128 related articles for article (PubMed ID: 8773259)
1. AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal formation of patients with Alzheimer's disease.
Ikonomovic MD; Sheffield R; Armstrong DM
Hippocampus; 1995; 5(5):469-86. PubMed ID: 8773259
[TBL] [Abstract][Full Text] [Related]
2. Distribution of glutamate receptor subunit NMDAR1 in the hippocampus of normal elderly and patients with Alzheimer's disease.
Ikonomovic MD; Mizukami K; Warde D; Sheffield R; Hamilton R; Wenthold RJ; Armstrong DM
Exp Neurol; 1999 Nov; 160(1):194-204. PubMed ID: 10630204
[TBL] [Abstract][Full Text] [Related]
3. AMPA-selective glutamate receptor subtype immunoreactivity in the hippocampal dentate gyrus of patients with Alzheimer disease. Evidence for hippocampal plasticity.
Armstrong DM; Ikonomovic MD
Mol Chem Neuropathol; 1996; 28(1-3):59-64. PubMed ID: 8871942
[TBL] [Abstract][Full Text] [Related]
4. AMPA-selective glutamate receptor subtype immunoreactivity in the aged human hippocampal formation.
Ikonomovic MD; Sheffield R; Armstrong DM
J Comp Neurol; 1995 Aug; 359(2):239-52. PubMed ID: 7499527
[TBL] [Abstract][Full Text] [Related]
5. Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage.
Carter TL; Rissman RA; Mishizen-Eberz AJ; Wolfe BB; Hamilton RL; Gandy S; Armstrong DM
Exp Neurol; 2004 Jun; 187(2):299-309. PubMed ID: 15144856
[TBL] [Abstract][Full Text] [Related]
6. Age-related loss of the AMPA receptor subunits GluR2/3 in the human nucleus basalis of Meynert.
Ikonomovic MD; Nocera R; Mizukami K; Armstrong DM
Exp Neurol; 2000 Dec; 166(2):363-75. PubMed ID: 11085901
[TBL] [Abstract][Full Text] [Related]
7. Aberrant localization of MAP5 immunoreactivity in the hippocampal formation in Alzheimer's disease.
Geddes JW; Lundgren K; Kim YK
J Neurosci Res; 1991 Sep; 30(1):183-91. PubMed ID: 1795403
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of GABA(A) receptor beta2/3 subunits in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes.
Mizukami K; Ikonomovic MD; Grayson DR; Rubin RT; Warde D; Sheffield R; Hamilton RL; Davies P; Armstrong DM
Exp Neurol; 1997 Oct; 147(2):333-45. PubMed ID: 9344558
[TBL] [Abstract][Full Text] [Related]
9. Glutamate receptor 1-immunopositive neurons in the gliotic CA1 area of the mouse hippocampus after pilocarpine-induced status epilepticus.
Tang FR; Chia SC; Zhang S; Chen PM; Gao H; Liu CP; Khanna S; Lee WL
Eur J Neurosci; 2005 May; 21(9):2361-74. PubMed ID: 15932595
[TBL] [Abstract][Full Text] [Related]
10. Localization of non-N-methyl-D-aspartate glutamate receptors in normal and Alzheimer hippocampal formation.
Hyman BT; Penney JB; Blackstone CD; Young AB
Ann Neurol; 1994 Jan; 35(1):31-7. PubMed ID: 8285589
[TBL] [Abstract][Full Text] [Related]
11. Synaptic plasticity and functional stabilization in the hippocampal formation: possible role in Alzheimer's disease.
Cotman CW; Anderson KJ
Adv Neurol; 1988; 47():313-35. PubMed ID: 3278521
[TBL] [Abstract][Full Text] [Related]
12. Alz-50 immunoreactive neuropil differentiates hippocampal complex subfields in Alzheimer's disease.
Brady DR; Mufson EJ
J Comp Neurol; 1991 Mar; 305(3):489-507. PubMed ID: 2037717
[TBL] [Abstract][Full Text] [Related]
13. Glutamate-, glutaminase-, and taurine-immunoreactive neurons develop neurofibrillary tangles in Alzheimer's disease.
Kowall NW; Beal MF
Ann Neurol; 1991 Feb; 29(2):162-7. PubMed ID: 1672808
[TBL] [Abstract][Full Text] [Related]
14. Alterations of ubiquitin immunoreactivity in the hippocampal formation after perforant pathway lesion.
Mizukami K; Ishikawa M; Iwakiri M; Hidaka S; Kato N; Asada T
Acta Neuropathol; 2002 May; 103(5):453-7. PubMed ID: 11935260
[TBL] [Abstract][Full Text] [Related]
15. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease.
Hyman BT; Kromer LJ; Van Hoesen GW
Ann Neurol; 1987 Mar; 21(3):259-67. PubMed ID: 3606033
[TBL] [Abstract][Full Text] [Related]
16. Distribution of AMPA receptor subunits in the hippocampal formation of temporal lobe epilepsy patients.
Lynd-Balta E; Pilcher WH; Joseph SA
Neuroscience; 1996 May; 72(1):15-29. PubMed ID: 8730702
[TBL] [Abstract][Full Text] [Related]
17. Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer's disease.
Ryoo HL; Joyce JN
J Comp Neurol; 1994 Oct; 348(1):94-110. PubMed ID: 7814686
[TBL] [Abstract][Full Text] [Related]
18. Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus.
Morris CM; Kerwin JM; Edwardson JA
Neurodegeneration; 1994 Dec; 3(4):267-75. PubMed ID: 7842297
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer-related tau-pathology in the perforant path target zone and in the hippocampal stratum oriens and radiatum correlates with onset and degree of dementia.
Thal DR; Holzer M; Rüb U; Waldmann G; Günzel S; Zedlick D; Schober R
Exp Neurol; 2000 May; 163(1):98-110. PubMed ID: 10785448
[TBL] [Abstract][Full Text] [Related]
20. Glutamate AMPA receptors in the fascia dentata of human and kainate rat hippocampal epilepsy.
Babb TL; Mathern GW; Leite JP; Pretorius JK; Yeoman KM; Kuhlman PA
Epilepsy Res; 1996 Dec; 26(1):193-205. PubMed ID: 8985700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
